www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

GBR-12909

Supplier:
Catalogue number:
B3043-25
Size:
25 mg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£435.00 Estimated delivery Wed 23 Jun
Shipping is calculated in checkout

GBR-12909 is a potent and selective inhibitor of dopamine uptake (Ki = 1 nM). It inhibits dopamine uptake in tissue slices obtained from rat neostriatum at nanomolar concentrations. GBR-12909 (10 mg/kg IP) produces a dose-dependent decrease in the binding of cocaine to the dopamine transporter in rats. It antagonises the ability of cocaine to elevate extracellular dopamine. It is also a potent blocker of cardiac hERG, sodium and calcium channels and shows cardiac antiarrhythmic properties. It is a potent ligand for sigma receptor. Regulators of sigma receptors are suggested to show activity against COVID-19, based on viral assay screens

Product Type:

Biochemicals

CAS Number:

67469-69-6

Storage Temp:

-20°C

Compound Purity:

≥98%

Molecular Weight:

450.56

UNSPSC Code:

12352200

GBR-12909

GBR-12909

Details Cat number & supplier Size Price
Cepharanthine B3042-50 · BioVision
B3042-50
BioVision
50 mg £307.00
50 mg
view
GBR-12909 B3043-5 · BioVision
B3043-5
BioVision
5 mg £109.00
5 mg
view
Cepharanthine B3042-10 · BioVision
B3042-10
BioVision
10 mg £77.00
10 mg
view
Ditolylguanidine B3044-100 · BioVision
B3044-100
BioVision
100 mg £77.00
100 mg
view
Nitazoxanide B3041-50 · BioVision
B3041-50
BioVision
50 mg £77.00
50 mg
view
Ditolylguanidine B3044-500 · BioVision
B3044-500
BioVision
500 mg £249.00
500 mg
view
Nitazoxanide B3041-250 · BioVision
B3041-250
BioVision
250 mg £307.00
250 mg
view